In addition, regulating this Rho-ROCK pathway could not only benefit individuals with PD, but also those with hypertension, angina, vasospasm, atherosclerosis, stroke, heart failure, coronary vasospasm, endothelial dysfunction, AD, HD, and ALS, as Rho-ROCK is implicated in these disorders. This evidence concerns the gene RHO and angina pectoris.